These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 12152160)
1. Expression of drs mRNA in human lung adenocarcinomas. Shimakage M; Takami K; Kodama K; Mano M; Yutsudo M; Inoue H Hum Pathol; 2002 Jun; 33(6):615-9. PubMed ID: 12152160 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of drs mRNA in human colon adenocarcinomas. Shimakage M; Kawahara K; Kikkawa N; Sasagawa T; Yutsudo M; Inoue H Int J Cancer; 2000 Jul; 87(1):5-11. PubMed ID: 10861446 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of drs tumor suppressor gene in highly malignant human pulmonary neuroendocrine tumors. Shimakage M; Kodama K; Kawahara K; Kim CJ; Ikeda Y; Yutsudo M; Inoue H Oncol Rep; 2009 Jun; 21(6):1367-72. PubMed ID: 19424611 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of drs mRNA in human prostate carcinomas. Kim CJ; Shimakage M; Kushima R; Mukaisho K; Shinka T; Okada Y; Inoue H Hum Pathol; 2003 Jul; 34(7):654-7. PubMed ID: 12874760 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of drs mRNA in colorectal neoplasms. Mukaisho K; Suo M; Shimakage M; Kushima R; Inoue H; Hattori T Jpn J Cancer Res; 2002 Aug; 93(8):888-93. PubMed ID: 12716466 [TBL] [Abstract][Full Text] [Related]
6. Suppression of anchorage-independent growth of human cancer cell lines by the drs gene. Yamashita A; Hakura A; Inoue H Oncogene; 1999 Aug; 18(34):4777-87. PubMed ID: 10490811 [TBL] [Abstract][Full Text] [Related]
7. Tumor prone phenotype of mice deficient in a novel apoptosis-inducing gene, drs. Tambe Y; Yoshioka-Yamashita A; Mukaisho K; Haraguchi S; Chano T; Isono T; Kawai T; Suzuki Y; Kushima R; Hattori T; Goto M; Yamada S; Kiso M; Saga Y; Inoue H Carcinogenesis; 2007 Apr; 28(4):777-84. PubMed ID: 17088259 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of drs mRNA expression is associated with the progression of adult T-cell leukemia/lymphoma. Shimakage M; Inoue N; Ohshima K; Kawahara K; Yamamoto N; Oka T; Tambe Y; Yasui K; Matsumoto K; Yutsudo M; Inoue H Int J Oncol; 2007 Jun; 30(6):1343-8. PubMed ID: 17487354 [TBL] [Abstract][Full Text] [Related]
9. Mucin mRNA expression in lung adenocarcinoma cell lines and tissues. Yu CJ; Yang PC; Shew JY; Hong TM; Yang SC; Lee YC; Lee LN; Luh KT; Wu CW Oncology; 1996; 53(2):118-26. PubMed ID: 8604237 [TBL] [Abstract][Full Text] [Related]
10. Suppression subtractive hybridization identified differentially expressed genes in lung adenocarcinoma: ERGIC3 as a novel lung cancer-related gene. Wu M; Tu T; Huang Y; Cao Y BMC Cancer; 2013 Feb; 13():44. PubMed ID: 23374247 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of KAI1 messenger RNA expression is not associated with loss of heterozygosity of the KAI1 gene region in lung adenocarcinoma. Tagawa K; Arihiro K; Takeshima Y; Hiyama E; Yamasaki M; Inai K Jpn J Cancer Res; 1999 Sep; 90(9):970-6. PubMed ID: 10551326 [TBL] [Abstract][Full Text] [Related]
12. Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells. Kim CJ; Yoshioka N; Tambe Y; Kushima R; Okada Y; Inoue H Int J Cancer; 2005 Oct; 117(1):51-8. PubMed ID: 15880581 [TBL] [Abstract][Full Text] [Related]
13. IMP3 expression is correlated with histologic grade of lung adenocarcinoma. Findeis-Hosey JJ; Yang Q; Spaulding BO; Wang HL; Xu H Hum Pathol; 2010 Apr; 41(4):477-84. PubMed ID: 20004948 [TBL] [Abstract][Full Text] [Related]
14. Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas. Chen G; Wang H; Miller CT; Thomas DG; Gharib TG; Misek DE; Giordano TJ; Orringer MB; Hanash SM; Beer DG J Pathol; 2004 Mar; 202(3):321-9. PubMed ID: 14991897 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of matrix Gla protein messenger RNA in human colorectal adenocarcinomas. Fan C; Sheu D; Fan H; Hsu K; Allen Chang C; Chan E Cancer Lett; 2001 Apr; 165(1):63-9. PubMed ID: 11248420 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas. Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423 [TBL] [Abstract][Full Text] [Related]
17. The drs tumor suppressor regulates glucose metabolism via lactate dehydrogenase-B. Tambe Y; Hasebe M; Kim CJ; Yamamoto A; Inoue H Mol Carcinog; 2016 Jan; 55(1):52-63. PubMed ID: 25620379 [TBL] [Abstract][Full Text] [Related]
18. Detection of laminin receptor mRNA in human cancer cell lines and colorectal tissues by in situ hybridization. Campo E; Monteagudo C; Castronovo V; Claysmith AP; Fernandez PL; Sobel ME Am J Pathol; 1992 Nov; 141(5):1073-83. PubMed ID: 1443045 [TBL] [Abstract][Full Text] [Related]
19. Cancer cells overexpress mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small-cell lung cancer tissue: analysis by Northern blotting and in situ hybridization. Morita S; Sato A; Hayakawa H; Ihara H; Urano T; Takada Y; Takada A Int J Cancer; 1998 Oct; 78(3):286-92. PubMed ID: 9766559 [TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor activation and overexpression upregulated fibroblast growth factor-9 in human lung adenocarcinomas. Wang CK; Chang H; Chen PH; Chang JT; Kuo YC; Ko JL; Lin P Int J Cancer; 2009 Aug; 125(4):807-15. PubMed ID: 19358281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]